Connexin 43 inhibition sensitizes chemoresistant glioblastoma cells to temozolomide

Resistance of glioblastoma (GBM) to the front-line chemotherapeutic agent temozolomide (TMZ) continues to challenge GBM treatment efforts. The repair of TMZ-induced DNA damage by O-6-methylguanine-DNA methyltransferase (MGMT) confers one mechanism of TMZ resistance. Paradoxically, MGMT-deficient GBM...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Res
Glavni autori: Murphy, Susan F, Varghese, Robin T, Lamouille, Samy, Guo, Sujuan, Pridham, Kevin J, Kanabur, Pratik, Osimani, Alyssa M, Sharma, Shaan, Jourdan, Jane, Rodgers, Cara M, Simonds, Gary R, Gourdie, Robert G, Sheng, Zhi
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5113032/
https://ncbi.nlm.nih.gov/pubmed/26542214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-15-1286
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items